The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
出版年份 2013 全文链接
标题
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
作者
关键词
Adherence, Alendronate, Ibandronate, Intravenous, Persistence, Postmenopausal osteoporosis
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 25, Issue 1, Pages 339-347
出版商
Springer Nature
发表日期
2013-10-02
DOI
10.1007/s00198-013-2515-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW)
- (2012) Daniel Prieto-Alhambra et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2012) Elaine M. Dennison et al. BONE
- A new taxonomy for describing and defining adherence to medications
- (2012) Bernard Vrijens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Persistence and compliance of medications used in the treatment of osteoporosis analysis using a large scale, representative, longitudinal German database
- (2012) Volker Ziller et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women
- (2011) V. Breuil et al. OSTEOPOROSIS INTERNATIONAL
- Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™
- (2011) E. Barrett-Connor et al. OSTEOPOROSIS INTERNATIONAL
- GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- (2011) G. Bianchi et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates for post-menopausal osteoporosis: are they all the same?
- (2011) R. Rizzoli QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Osteoporosis: burden, health care provision and opportunities in the EU
- (2011) O. Ström et al. Archives of Osteoporosis
- Oral bisphosphonate compliance and persistence: a matter of choice?
- (2010) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Compliance and persistence with osteoporosis medications: A critical review of the literature
- (2010) Stuart Silverman et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
- (2009) Ethel S. Siris et al. AMERICAN JOURNAL OF MEDICINE
- Improving the Prediction of Medication Compliance
- (2009) Jeffrey R. Curtis et al. MEDICAL CARE
- The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design
- (2009) F. H. Hooven et al. OSTEOPOROSIS INTERNATIONAL
- Effectiveness of bisphosphonate therapy in a community setting
- (2008) Adrianne C. Feldstein et al. BONE
- Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)
- (2008) Peyman Hadji et al. JOINT BONE SPINE
- Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization
- (2008) J. A. Sunyecz et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now